04 Aug Growing wealth of data leading to better outcomes for cancer patients
As researchers search for novel ways to treat and better understand cancer, a growing wealth of data is making these efforts more successful than ever before.
“As with any problem, the better we understand it and the more data we get, the more likely that we are going to figure some things out,” said Howard Bailey, director of the University of Wisconsin Carbone Cancer Center.
He spoke as part of a panel at a recent meeting of the Wisconsin Technology Council’s Innovation Network in Madison. Also present were Chorom Pak, co-founder and president of biotech startup Lynx Biosciences, and David Beebe, another co-founder and a professor of biomedical engineering at UW-Madison.
Pak gave an update on the company’s progress in moving toward a marketable form of its MicroC3 device, which can measure the therapeutic response of a patient’s tumor cells alongside non-tumor cells. It acts as a sort of test-run for blood cancer treatments, evaluating their effectiveness without having to use the patient as a guinea pig.
Sorry, the comment form is closed at this time.